missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human VEGFR3 (Flt-4) Fc Chimera Recombinant Protein
missing translation for 'orderingAttributeHoverText'
Quantity:
1 mg
100 μg
missing translation for 'unitSize'
100µg
1mg
Description
It is recommended that the protein be aliquoted for optimal storage. It is recommended that sterile water (900 μL) be added to the vial to prepare a stock solution of 1.11 mg/mL. Concentration is measured by UV.
Vascular endothelial growth factor is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGFC stimulates the growth of lymphatic vessels through its specificl ymphatic endothelial receptor VEGFR-3. In 1998, Dumont showed that targeted inactivation of the VEGFR-3 gene in mice resulted in defective blood vessel development in early embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR3 has an essential role in the development of theembryonic cardiovascular system before the emergence of the lymphatic vessels.
Specifications
Specifications
| Accession Number | P35916 |
| For Use With (Application) | Control, ELISA Standard, Binding Assay |
| Format | Lyophilized |
| Formulation | PBS with 0.01% mannitol, 5-8% trehalose, 0.01% Tween 80 and no preservative; pH 7.4 |
| Gene ID (Entrez) | 2324 |
| Molecular Weight (g/mol) | 111.3 kDa |
| Name | Human VEGFR3 (Flt-4) Fc Chimera |
| pH Range | 7.4 |
| Purification Method | Purified |
| Quantity | 1 mg |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction